epithelial tumor
Showing 1 - 4 of 4
Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)
Recruiting
- Metastatic Cancer
- Epithelial Tumor
- NG-641
-
Los Angeles, California
- +5 more
Jan 16, 2023
Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)
Recruiting
- Epithelial Tumor
- Metastatic Cancer
- NG-350A plus Pembrolizumab
-
Santa Monica, California
- +3 more
May 4, 2022
Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)
Recruiting
- Metastatic Cancer
- Epithelial Tumor
- NG-641 in combination with Nivolumab
-
Santa Monica, California
- +2 more
Mar 16, 2022
Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, Epithelial Tumor Trial in United States (enadenotucirev,
Completed
- Colorectal Cancer
- +2 more
- enadenotucirev
- nivolumab
-
Tucson, Arizona
- +5 more
Nov 2, 2021